Oncotelic closes initial $800K convertible note offering at 12% with warrants

Oncotelic Therapeutics, Inc.

Issued 32 units at $25,000 each to 21 accredited investors; total $800,000 raised.
Each unit consists of a 2-year 12% note convertible into Oncotelic stock at $0.10/share or EdgePoint AI stock at $1.00/share.
Each unit also includes warrants to buy 250,000 Oncotelic shares at $0.12 or 25,000 EdgePoint warrants at $1.25.
Offering allows up to 500 units ($12.5M); prior 2023 PPM note exchanged as part of deal.
Registration rights granted for shares issuable under the units and warrants.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.